latest Bloomberg report states Many Clinicians are not aware of an effective alternative to Tamiflu. RELENZA Sales of tamiflu in 2006 $2.4 billion Sales of relenza $180 million.
How can Glaxo possibably think they can win the court case. More damning evidence they have not marketed Relenza. Damages should be double what Biota are asking for.
